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BACKGROUND
Over the last few years, the epidemics of noncommunicable
diseases and the need for cost-containment1 are triggering factors
for a profound transformation of the way we approach delivery of
care for chronic patients. In this new scenario, conventional
disease-oriented approaches, centered on the management
of clinical episodes, are being replaced by patient-centered
integrated care services,2 as promoted by the World Health
Organization.3
Lessons learnt from deployment experiences4, 5 following
patient-centered approaches are being disseminated as good
practices.6 However, there are several factors that need further
attention, such as the need for further assessment of implementa-
tion strategies in real-world scenarios and the lack of transfer-
ability from progress achieved in disease-oriented integrated care
to management of complex chronic patients (CCP).5, 7 Likewise,
efﬁcacy achieved in integrated care interventions, assessed
through randomized controlled trials,8–11 may not translate into
effectiveness at health system level.12
In addition, poor comparability among experiences on manage-
ment of multimorbidity emerges as an important hurdle for the
adoption of integrated care. In this regard, the lack of an
operational deﬁnition for CCP is not a negligible factor, as it
clearly limits an appropriate service workﬂow design, which, in
turn, precludes both evaluation and comparability of reported
experiences.5–7
The term CCP is usually applied to subjects with heterogeneous
conditions that may depict at least one of the following three
traits: (i) need for management by several specialists from
different disciplines generating high use of healthcare resources;
(ii) frailty,13 requiring additional support either due to functional
decline, social deﬁcits, and/or transient situations like post-
hospital discharge14–16; or, (iii) need for highly specialized care
with home-based technological support.4 Moreover, CCP often
show a dynamic evolution over time in terms of both health risk
and care requirements,6 such that their management requires a
balance between planned (predeﬁned and repeatable) and
unplanned processes (depending on evolving circumstances and
ad-hoc decisions).
The CCP protocol relies on the hypothesis that implementation
of (i) structured, but ﬂexible service workﬂows, that is, a
collaborative and adaptive case management approach17 and (ii)
enhanced patient health risk assessment and stratiﬁcation can
overcome current limitations of multimorbidity management. The
protocol for management of CCP aims to assess the study
hypothesis through the evaluation of the regional deployment of
two existing integrated care interventions (i.e., implementation
studies) described below. It is of note that the protocol evaluation
will also include a population-based analysis of CCP management.
The two implementation studies have a quasi-experimental
design. That is, a nonrandomized intervention group (integrated
care) is compared to a control group (usual care) using propensity
score methods18 wherein age, gender, and population-based
health risk assessment are the main variables to be used for
adjustment. The Catalan population-based health risk assessment
tool (GMA, Adjusted Morbidity Groups)19, 20 will be used for health
risk scoring purposes. The protocol evaluation follows a Triple Aim
approach21, 22 considering predeﬁned outcome variables for (i)
health and well-being, (ii) experience with care, and (iii) costs.
Assessment will be carried out combining empirical questionnaire
data collection, information from electronic medical records, and
registry data. The main study outcome will be twofold: (i)
demonstration of cost-effectiveness of the interventions; and, (ii)
identiﬁcation of factors that modulate success of large-scale
deployment. A post-hoc statistical power analyses for assessment
of the main protocol outcomes will be done.
AIMS
The protocol addresses the ﬁve aims displayed in Fig. 1. Firstly,
execution of implementation studies of two integrated care
interventions with proven efﬁcacy in previous studies4: (i)
Community-based management of CCP and, (ii) Integrated care
for patients under long-term oxygen therapy (LTOT). The two
implementation studies will allow (second aim) to assess the
impact of collaborative adaptive case managment17 supported by
information and communication technologies. The third aim of
the protocol is to evaluate the impact of enhanced clinical health
risk assessment and stratiﬁcation19 on the two implementation
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studies. The fourth aim is assessment of healthcare value
generation23, 24 of the interventions, both during the deployment
phase and after regional scaleup of the services. Finally, the
current study will generate a roadmap for regional adoption of the
CCP protocol.
DISCUSSION
The current protocol describes a comprehensive strategy for
achieving regional adoption of integrated care for complex
chronic patients in Catalonia. It relies on two main innovative
pillars: (i) Technological platforms to support service workﬂows
based on collaborative and adaptive case management of CCP;
and, (ii) Highly transferable enhanced clinical risk assessment and
stratiﬁcation strategy. To our knowledge, the current protocol
design shows key factors required to overcome limitations
observed in other regional deployments.
In summary, the CCP protocol articulates lessons learnt in
previous experiences4 carried out and validated in Catalonia
during the last few years in order to generate a collaborative
ecosystem with high potential for transferability to other
geographical areas. The main project outcome will be generation
of guidelines for large-scale deployment of the CCP protocol,
including transferability analysis that shall facilitate adoption of
cost-effective integrated care services for management of
multimorbidity.
METHODS
The setting
The current manuscript describes the protocol for large-scale deployment
of integrated care services for CCP undertaken in the healthcare sector of
Barcelona-Esquerra (520k citizens) and in two other areas of Catalonia:
Badalona Serveis Assistencials (420k citizens) and Lleida (366k citizens). The
protocol for regional deployment of CCP management in Catalonia (ES)
(7.5M citizens) is being developed under the umbrella of the Catalan
Government Health Plan 2016–2020,25 and it is supported by the
convergence of resources among innovation plans of healthcare providers,
public resources, and manpower from different grants.26 The research was
submitted to the Ethical Committee of the Hospital Clínic of Barcelona, and
it has been registered as at clinicaltrials.gov (NCT02956395—Implementa-
tion of Community-based Collaborative Management of Complex Chronic
Patients (Nextcare_CCP)).
In the other two sites (Lleida and Badalona), the two implementation
studies will begin by mid-2017 in order to facilitate site adaptation of the
service workﬂows. An initial assessment of all implementation studies will
be done after 18 months of the trials initiation in each of the sites. The
timeline of the CCP integrated care intervention is indicated in Fig. 2.
Implementation studies
While the total protocol duration will be 42 months, from mid-2016 to end
of 2019 (Fig. 2), on January 2017, two implementation studies were
initiated at Barcelona-Esquerra: (i) Community-based management of CCP
(intervention group, n = 3000) and (ii) Integrated care for patients under
LTOT (intervention group, n = 500).27 A codesign process (Supplementary
Methods) following a Plan–Do–Study–Act methodology28 will be carried
out in each site by a multidisciplinary team including: primary care
professionals (general practitioners, nurses, and social workers),
specialists (doctors and allied health professionals), technologists,
patients, and caregivers.
The integrated care intervention for community-based management of
CCP. The integrated care intervention for community-based manage-
ment of CCP constitutes the core implementation study in the protocol.
The service workﬂow (Fig. 3) has two sequential phases with speciﬁc target
outcomes for each of them: (i) Short-term intervention to prevent early (30
and 90 days) hospital-related events; and (ii) Intervention to enhance
community-based long-term management of CCP.
Eligible candidates for inclusion are patients showing moderate-to-high
risk of early readmission (LACE index≥ 7)29 recruited immediately after
hospital discharge. Additional inclusion criteria to be fulﬁlled by candidates
are as follows: (i) living in his/her house within the healthcare sector; (ii)
having a phone at home; and, (iii) signing a written acceptance form to
Fig. 1 Aims of the study. Five pivotal aims to achieve successful regional adoption of the community-based protocol for collaborative
management of complex chronic patients across healthcare tiers
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participate in the implementation study. The exclusion criteria for the
study are patients with severe psychiatric or neurologic disorders
impeding patient collaboration.
The intervention is implemented by a multidisciplinary team from the
hospital and primary care consisting of advanced practice nurses,
physicians, physiotherapists, community nurses, and social workers, having
a general practitioner as a reference. The collaboration between
specialized care and primary care is guided by the reform of specialized
care in the healthcare sectors initiated in 2006. This reform30 aimed to
improve healthcare quality and accessibility, based on coordination
between the Hospital Clínic and the different suppliers to the integrated
health area of Barcelona-Esquerra. The challenge for Hospital Clinic is to
work simultaneously as a dual hospital: high-tech (as a national reference
center) and as a community hospital for the healthcare sector. For the
Fig. 3 General service workﬂow. General description of the service workﬂow through six sequential steps
Fig. 2 Timeline of the protocol for large-scale deployment of CCP management in Catalonia. AISBE stands for integrated care area of
Barcelona-Esquerra and BSA is the abbreviation of Barcelona Serveis Assistencials. A total of four codesign cycles, of 6-month duration each,
are planned in each site. At the end of the assessment of the implementation studies (M42), a consensus on key performance indicators for
follow up of integrated care interventions’ adoption beyond the current study will be achieved
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development of the reform, a follow-up body was set up with
differentiated working groups to deﬁne the organizational structure, the
information systems requirements, and the care processes.
The intervention during hospital admission includes a comprehensive
assessment of the patient at entry including severity of the primary
disease, evaluation of comorbid conditions and analysis of social support
needs. Moreover, a 2-h educational program is administered by a nurse
followed by distribution of patient-speciﬁc support material. The educa-
tional program covers knowledge of primary disease and comorbidities,
instructions on nonpharmacological treatment, administration techniques
for proper pharmacological therapy, and techniques for self-management
of the disease along with comorbid conditions, including strategies to
prevent future severe exacerbations.
The intervention includes a phone call at 24 h and a home visit at 72 h
after hospital discharge by one member of the multidisciplinary team, if
needed. During this home visit, the therapeutic plan for each patient will
be customized to their individual frailty factors and shared with the
primary care team. Reinforcement of the logistics for treatment of
comorbidities and social support will be done accordingly. Moreover, the
personal health folder will be used for patient empowerment for self-
management and as a tool to facilitate accessibility to health professionals.
The personal health folder of Catalonia (https://lamevasalut.gencat.cat)
provides citizens with an access point to their clinical information (i.e.,
electronic prescriptions, administered vaccines, diagnosis, clinical reports,
and diagnostic/lab tests) and can also act as the citizen entry point for
some of the supported administrative processes (e.g., appointments),
interactions with health professionals, and potentially for connection with
informal health data sources (e.g., mobile health applications and
community social support services).
The advance-practice nurses perform regular training sessions to the
community-based care teams, coordinate accessibility to specialized care
as needed, and support functionalities of the personal health folder for the
patients admitted into the protocol. The number of home care visits, as
well as access to specialized care during the follow-up of a 12-month
period, is individually tailored, and dynamically adapted, to patient needs.
Moreover, planned visits by specialized professionals can be scheduled
through day hospital or home visits if primary care teams consider this
necessary.
The integrated care intervention for management of patients currently under
LTOT. The integrated care intervention for management of patients
currently under LTOT was selected for inclusion in the current protocol
because patients under LTOT constitute a representative group of frail
multimorbid individuals requiring cooperative management of multiple
actors including community-based health care professionals, specialists,
and companies providing home-based services (Fig. 4). The characteristics
and unmet needs of the LTOT group of patients in Barcelona-Esquerra have
been described in detail elsewhere.27 The focus of the study is the analysis
of the impact of technological tools supporting collaborative management
on main outcomes, namely: (i) adequacy of prescription; (ii) adherence; and,
(iii) enhanced community-based management of the patients.
Adoption of ICT supported adaptive case management
The general structure of the service workﬂows in the protocol
encompasses ﬁve main steps: (1) Case identiﬁcation—It refers to
identiﬁcation of candidates for inclusion into the protocol following
predeﬁned inclusion/exclusion criteria; (2) Case evaluation—Initial holistic
Fig. 4 Integrated Care Management of patients under LTOT
Fig. 5 Stratiﬁcation of the Catalan population (2014) using the GMA. Previously published in Dueñas-Espín I et al., BMJ Open. 2016 Apr 15;6(4)
as part of the online supplementary material (Supplementary Figure 2S). The third and fourth columns depict rates of mortality and hospital
admissions, respectively. The ﬁfth column indicates the cost per inhabitant per year expressed in € and the last column refers the percentage
of total healthcare expenditure by risk strata. It is of note that the closer the patient is to the tip of the pyramid, the higher are mortality, risk of
hospital admission, and healthcare expenses. Green color (bottom) indicates healthy status, whereas red (tip) corresponds to maximum risk of
admissions and highest mortality risk
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Table 1. Predeﬁned outcome variables for evaluation purposes selected with a “Triple Aim” approach
Triple Aim Outcome Data source and Instrument
Health and well-being Sociodemographics Catalan Health Surveillance System and Electronic Medical Records
Multimorbidities Catalan Health Surveillance System and Electronic Medical Records
Patient Clinical Data Electronic Medical Records
Health-related quality of life SF-36 questionnaire37
Therapeutic plan (Pharmacological/Others) Catalan Health Surveillance System and Electronic Medical Records
Intermediate outcomes (see costs): Catalan Health Surveillance System
• Emergency department visits
• General practitioner visits
• Cumulative days per year admitted in hospital
• Multiple drugs’ prescription
• Potentially avoidable hospitalizations
• Hospital readmissions
• Needs for social support
Mortality Catalan Health Surveillance System/Electronic Medical Records
Physical functioning Short Form 36 (SF-36)37, (1) or Katz-1538, (1)
Psychological well-being Mental Health Inventory (MHI-5) of the Short Form 3637, (1)
Social relationships and participation Impact on Participation and Autonomy (IPA)39, (1)
Enjoyment of life Investigating Choice Experiments for the Preferences of Older
People (ICECAP-O)40, (1)
Resilience Brief Resilience Scale (BRS)41 (1)
Autonomy Pearlin Mastery Scale42, (1)
Activation and engagement Short form Patient Activation Measure (PAM-13)43, (1)
Experience with care Person centeredness Person-Centered Coordinated Care Experiences Questionnaire
(P3CEQ)44, (1)
Continuity of care Nijmegen Continuity Questionnaire (NCQ)45 (1)
Burden of medication Living with Medicines Questionnaire (LMQ)46, (1)
Burden of informal caregiving Informal Care Questionnaire47, (1)
Use of the Personal Health Folder Catalan Health Surveillance System
Access to integrated care Catalan Health Surveillance System
Healthy lifestyle (Tobacco/Nutrition/Alcohol/Physical
Activity)
Electronic Medical Records
Knowledge of current morbid conditions Electronic Medical Records (nonstandard questionnaire)
Multiple drug therapy Catalan Health Surveillance System and Morinsky-Green
questionnaire48
Home-based technological support Electronic Medical Records
Patient satisfaction and engagement Electronic Medical Records (nonstandard questionnaire)
Caregiver satisfaction and engagement Electronic Medical Records (nonstandard questionnaire)
Costs(2) Total health and social care cost Catalan Health Surveillance System
Primary Care Catalan Health Surveillance System
Hospital-related Care Catalan Health Surveillance System
• Admissions
• Emergency room consultations
• Outpatient specialized care
Pharmacy Catalan Health Surveillance System
Mental Health Catalan Health Surveillance System
Sociosanitary services Catalan Health Surveillance System
Other costs Catalan Health Surveillance System
• Respiratory therapies
• Dialysis
• Rehabilitation
• Nonurgent patient transport
(1) Questionnaire administered within the EU project SELFIE (see methods in Supplementary Section 1 for further details)
(2) The Catalan Health Surveillance System registries (Supplementary Figure 1) allow allocation of healthcare expenditure to each patient through the Personal
Health Identiﬁcation Number, which facilitates analysis of total healthcare expenditure in complex patients
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characterization of the patient, including health risk assessment, done at
entry into the program; (3) Personalized work plan deﬁnition—Elaboration
of a personalized action plan based on case evaluation; (4) Work plan
execution, follow-up and event handling—Execution of the work plan will
be done with technological support to facilitate the protocol follow-up and
the handling of unexpected events by (i) fostering patient empowerment
for self-management; (ii) enhancing patient adherence to the protocol; (iii)
facilitating remote supervision; (iv) allowing patient monitoring; and (5)
Discharge—At the end of the protocol evaluation (Fig. 2), the patient can
remain in the program or he/she can be moved to other types of
integrated care services depending upon his/her needs.
Adoption of adaptive case management17, 31 to support collaborative
work constitutes an emergent approach that facilitates case managers to
adapt well-structured service workﬂows to the continuously evolving
needs of the patients. This implies selection and scheduling of speciﬁc
tasks during case management and ad-hoc collaboration with other
professionals across healthcare and social support tiers, which facilitates
collaborative decisions triggered by expected and unexpected events.
Therefore, the two target-integrated care interventions will be
supported by a software platform that will allow the execution of well-
structured but adaptable clinical workﬂows. This platform will be open-
source and built-up on top of the current health information systems of
the different healthcare providers and using existing regional interoper-
ability infrastructures. In order to support both patient collaborative work
and self-management, the personal health folder already deployed in the
region is currently being adapted for the purposes of the protocol as a key
component of the Catalan Digital Health Framework.32
Enhanced health risk assessment and stratiﬁcation
The CCP protocol acknowledges that health risk prediction and stratiﬁca-
tion is a relevant driver for large-scale deployment of integrated care.6
Accordingly, the project will use the regional population health risk
assessment tool (GMA) to enhance clinical risk assessment and stratiﬁca-
tion (Fig. 5).
Prospective assessment of both practicalities and added value of the use
of GMA scoring for enhanced clinical risk prediction and stratiﬁcation, as
reported in detail elsewhere,19 has been successfully completed in
Catalonia for the entire population of patients with Chronic Obstructive
Pulmonary Disease (unpublished). This approach will be incorporated in
the implementation studies undertaken into the current CCP protocol
aiming at enhancing risk prediction in the clinical scenario.
The GMA tool predicts individual patient risk based on multimorbidity
information gathered from the Catalan Health Surveillance System
described below. The rationale behind the use of GMA, against alternative
health risk assessment tools, is that it complies with four main
recommended criteria19; that is, (i) a population health approach (using
the entire source population of 7.5 million inhabitants of the region);
(ii) publicly owned without licensing constraints; (iii) open-source computa-
tional algorithms; and, (iv) the GMA morbidity grouper relies on statistical
criteria, as opposed to other tools that include expert-based coefﬁcients,
thus facilitating quick transferability to other territories, as recently shown in
Spain wherein GMA risk assessment is used in 38 million inhabitants.
Assessment of healthcare value generation
The evaluation strategy (see Supplementary Methods for further details) has
a threefold aim: (i) identiﬁcation of factors that modulate large-scale
deployment of the two implementation studies in the three sites; (ii)
assessment of cost-effectiveness of the intervention for enhanced
community-based management of CCP; and (iii) evaluation of the added
value of the technological support for integrated care management of
patients under LTOT. To this end, we will use implementation research
tools33, 34 organized within the frame of the Model for ASsesment of
Telemedicine applications.35 As alluded to above, the two implementation
studies have a quasiexperimental design wherein integrated care (interven-
tion) will be compared to usual care (control) with age, gender, and GMA
scoring as main matching variables. Moreover, a population-based analysis
of CCP management using registry data from the Catalan Health
Surveillance System (CHSS) (Supplementary Fig. 1) will be carried out
assessing separately intervention and control areas in each of the three sites.
Predeﬁned outcome variables (Table 1) will include the eleven indicators
recommended by the Spanish Health System36 for assessment of four care
coordination categories of variables. At the end of the study, we will
propose Key Performance Indicators, selected among those used in the
regional deployment phase, to be considered for population-based
assessment of integrated care interventions for CCP beyond the lifespan
of the study.
Data for evaluation purposes, for both implementation studies and
population-based analysis (Table 1 and Supplementary Fig. 1), will be
obtained from (i) Electronic Medical Records; (ii) the CHSS; and, (iii)
Standardized questionnaires selected with a “Triple Aim” approach,21, 22
this is, considering predeﬁned outcome variables for (i) health and well-
being, (ii) experience with care, and (iii) costs.
The CHSS (Supplementary Fig. 1) includes updated registries from
Primary Care, Hospital-related events (hospitalization, emergency room,
and specialized outpatient visits), Pharmacy, Mental Health, Sociosanitary
services, respiratory therapies, dialysis, outpatient rehabilitation, nonurgent
health transport, outpatient minor surgery, home hospitalization and
implants since 2011. It allows analyses on use of healthcare resources,
pharmacy consumption, and prevalence of key disorders. The CHSS also
feeds the population-based health risk assessment tool known, GMA, that
is used to elaborate the health risk strata pyramid of the general
population of Catalonia,19, 20 which is periodically updated on a 6-month
basis. The CHSS allows allocation of healthcare expenditure, including
pharmacy, to each patient through the Personal Health Identiﬁcation
Number, which facilitates analysis of total healthcare expenditure in
complex patients.
Data availability
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